Allergodip(R) India - Customised Allergen Panels For The Local Market

Top Quote Omega Diagnostics Group PLC successfully launched its Allergodip® India enzyme immunoassay (EIA) at the recent World Allergy Organization International Scientific Conference (WISC 2012), held in Hyderabad, India, from the 6th to the 9th of December. End Quote
  • (1888PressRelease) December 20, 2012 - Allergodip India is an adaptation of Omega Diagnostic's popular Allergodip assay, and offers customised allergen panels for the Indian marketplace. This semi-quantitative EIA for the determination of Specific IgE in serum or plasma is designed to screen for the most common triggers of allergic diseases in India, and is currently available as two panels; Inhalation - India, and Food - India.

    Allergodip India is an easy-to-use, simple test that generates a clear, visual result by comparison of the assay dipstick with a colour chart. No laboratory equipment is necessary, eliminating capital expenditure and the need for a service contract. Quality of results is ensured by integrated positive and negative controls, and the assay has a diagnostic specificity of 100 % and a sensitivity of 97.5 %. Allergodip India is supplied with ready-to-use reagents and requires minimal hands-on time, helping to reduce errors and saving time, freeing up staff for other activities. Allergodip India was very well received at the Conference, with many delegates expressing an interest in the new product. The recent opening of its direct subsidiary based in Mumbai in July 2012 will make this new range a key focus for Omega Diagnostics in India going forwards.

    For more information please contact:

    Omega Diagnostics Ltd

    Omega House,

    Hillfoots Business Village,


    FK12 5DQ


    United Kingdom

    Tel: +44 (0)1259 763030 Fax: +44 (0)1259 761853

    email: odl ( @ ) omegadiagnostics dot co dot uk

    About Omega Diagnostics Group PLC

    Omega Diagnostics Group PLC, based in Scotland, UK, is a public company AIM listed on the London Stock Exchange (Ticker Symbol: ODX). Formed in September 2006 when Omega Diagnostics Ltd completed a reverse acquisition of the AIM listed cash shell company, Quintessentially English PLC, the Group acquired Genesis Diagnostics Ltd and Cambridge Nutritional Sciences Ltd in September 2007, with bacterial disease diagnostic assay manufacturer Co-Tek (South West) Ltd joining the Group in September 2009. The IVD division of allergy and specific immunotherapy specialist Allergopharma Joachim Ganzer KG, a supplier of allergy tests for over 600 allergens, was acquired in December 2010 and, more recently, in 2011 the Group established a wholly owned Indian subsidiary, Omega DX (Asia) Pvt Ltd. Today, the Omega Diagnostics Group has a strong distribution network in over 100 countries, providing a wide range of high quality immunoassay-based products focused on the specialist fields of allergy/autoimmune disease, infectious disease and food intolerance to the in vitro diagnostics (IVD) market, for use in hospitals, blood banks, clinics and laboratories.

  • FB Icon Twitter Icon In-Icon
Contact Information